• Explore /
  • Poster
  • / A phase II study of early FDG-PET evaluation after one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy: Final report.

A phase II study of early FDG-PET evaluation after one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy: Final report.

Abstract Poster

Authors

null

Ta-Chen Huang

Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan

Ta-Chen Huang , Chia-Chi Lin , Kai-Yuan Tzen , Yun-Chun Wu , Jason Chia-Hsien Cheng , Jang-Ming Lee , Hsiu-Po Wang , Pei-Ming Huang , Feng-Ming Hsu , Kun-Huei Yeh , Ann-Lii Cheng , Chih-Hung Hsu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT01034332

Citation

J Clin Oncol 35, 2017 (suppl; abstr 4042)

DOI

10.1200/JCO.2017.35.15_suppl.4042

Abstract #

4042

Poster Bd #

34

Abstract Disclosures

Similar Posters

First Author: Satoru Matsuda

First Author: Lei Gong

First Author: Richard Francis Dunne

Poster

2021 Gastrointestinal Cancers Symposium

Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.

Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.

First Author: Wen Zhang